• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

Behavioral dysregulation in infancy predicts later child mental health

byMichael DinhandLeah Carr, MD
February 8, 2019
in Pediatrics, Psychiatry
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Infants classified as having moderately or severely unsettled behavioral regulation at 12 months of age had greater odds of having a positive behavioral screen for mental disorder at 11 years compared to settled infants.

2. Odds of reporting clinically significant mental health concerns appeared to increase over time for infants with moderately or severely unsettled behavioral regulation.

Evidence Rating Level: 2 (Good)

Study Rundown: In this prospective cohort study, researchers recruited mothers of infants in Australia to complete questionnaires about child demographic, health, and behavioral characteristics at 12 months, and followed with further questionnaires as well as a behavioral survey screening for mental disorder at 5 and 11 years. Infants were classified by behavioral regulation profile at 12 months of age based on degree of sleep, crying, temper tantrums, temperament, and feeding problems, and profiles were compared on rates mental health concerns later in childhood. Infants classified as having severely or severely unsettled behavioral regulation at 12 months of age had greater odds of having a positive behavioral screen for mental disorder at 11 years compared to settled infants; severely unsettled infants also had greater odds of screening positive at 5 years. Odds of reporting clinically significant mental health concerns appeared to increase over time for infants with moderately or severely unsettled behavioral regulation.

These findings are limited by questionnaire data that are only suggestive, not diagnostic for mental disorders. Only mothers, not children themselves, gave responses in this study. Nonetheless, the study is strengthened by its large sample and longitudinal, prospective design. For physicians, these findings highlight the importance of identifying infants with behavioral dysregulation early and enacting targeted interventions and referring to support services given their increased risk of later mental health concerns.

Click to read the study, published today in Pediatrics

RELATED REPORTS

The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave

Mental Health Chatbot Woebot Shown to Help with Postpartum Depression and Anxiety

The Scan by 2 Minute Medicine®: Climate-Driven Crises, Serena’s Mental Fitness Revolution, Superhuman Immunity, and Healthcare on Strike

Relevant reading: Long-term Outcomes of Infant Behavioral Dysregulation

In-Depth [prospective cohort]: Researchers collected questionnaire data on child demographic, health, and behavioral factors from 1759 mothers attending 8-month well-child appointments at child ages 8 to 10 months in 2003 and 2004, and follow-up questionnaire data at 12 months, 5 years, and 11 years. The parent-report Strengths and Difficulties Questionnaire (SDQ) was used to measure child behavioral characteristics at 5 and 11 years. Researchers used latent class analysis and linear and logistic regression models to relate infant behavioral regulation at 12 months of age to social, emotional, and behavioral outcomes at 5 and 11 years.

At 12 months of age, children were classified by infant regulation profile as settled (36.8%), isolated temper tantrums (21.3%), sleep problems (25.4%), moderately unsettled (13.2%), and severely unsettled (3.4%) based on degree of sleep, crying, temper tantrums, temperament, and feeding problems. Moderately unsettled children at 12 months were significantly more likely to score in the SDQ clinical range for total difficulties (odds ratio [OR] 2.85; 95% confidence interval [CI]: 1.28 to 6.36) at 11 years of age, and severely unsettled children had higher odds of scoring in the SDQ clinical range at 5 years of age (OR 9.35; 95%CI: 2.49 to 35.11) and 11 years of age (OR 10.37; 95%CI: 3.74 to 28.70).

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: mental healthprimary care
Previous Post

De novo design of artificial IL-2 mimic for the treatment of cancer [PreClinical]

Next Post

Quick Take: Association of Surgical Intervention for Adhesive Small-Bowel Obstruction With the Risk of Recurrence

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave

July 2, 2025
Parents often unaware of adolescents’ suicidal thoughts
AI Roundup

Mental Health Chatbot Woebot Shown to Help with Postpartum Depression and Anxiety

May 13, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Chronic Disease

The Scan by 2 Minute Medicine®: Climate-Driven Crises, Serena’s Mental Fitness Revolution, Superhuman Immunity, and Healthcare on Strike

May 7, 2025
2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Roundup

2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]

May 21, 2025
Next Post
Quick Take: Association of Surgical Intervention for Adhesive Small-Bowel Obstruction With the Risk of Recurrence

Quick Take: Association of Surgical Intervention for Adhesive Small-Bowel Obstruction With the Risk of Recurrence

Spleen elastography may be effective in the diagnosis of portal hypertension

Porphyria recurrence in a transplant recipient illustrates the need for genetic screening of related organ donors

Quick Take: Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials

Quick Take: Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nerandomilast slows FVC decline in progressive pulmonary fibrosis
  • 2 Minute Medicine: Pharma Roundup – Gastric Immunotherapy Gains, Prostate Pill Expansion, Five-Minute Myeloma Dosing, and Streamlined CAR-T Access [July 8th 2025]
  • 2 Minute Medicine Rewind July 7, 2025
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.